Toward Exosome-Based Neuronal Diagnostic Devices
Overview
Affiliations
Targeting exosome for liquid biopsy has gained significant attention for its diagnostic and therapeutic potential. For detecting neuronal disease diagnosis such as Alzheimer's disease (AD), the main technique for identifying AD still relies on positron-emission tomography (PET) imaging to detect the presence of amyloid-β (Aβ). While the detection of Aβ in cerebrospinal fluid has also been suggested as a marker for AD, the lack of quantitative measurements has compromised existing assays. In cerebrospinal fluid, in addition to Aβ, T-Tau, and P-Tau, alpha-synuclein has been considered a biomarker of neurodegeneration. This review suggests that and explains how the exosome can be used as a neuronal diagnostic component. To this end, we summarize current progress in exosome preparation/isolation and quantification techniques and comment on the outlooks for neuronal exosome-based diagnostic techniques.
Proteomics analysis of extracellular vesicles for biomarkers of autism spectrum disorder.
Moussa H, Shin K, de la Fuente A, Bensmail I, Abdesselem H, Ponraj J Front Mol Biosci. 2024; 11:1467398.
PMID: 39606031 PMC: 11599737. DOI: 10.3389/fmolb.2024.1467398.
Cheravi M, Baharara J, Yaghmaei P, Roudbari N Curr Stem Cell Res Ther. 2023; 19(7):1042-1054.
PMID: 37957915 DOI: 10.2174/011574888X270145231102062259.
Batool S, Yekula A, Khanna P, Hsia T, Gamblin A, Ekanayake E Cell Rep Med. 2023; 4(10):101198.
PMID: 37716353 PMC: 10591039. DOI: 10.1016/j.xcrm.2023.101198.
Exosomes as Novel Delivery Systems for Application in Traditional Chinese Medicine.
Chen Q, Wu D, Wang Y, Chen Z Molecules. 2022; 27(22).
PMID: 36431890 PMC: 9695524. DOI: 10.3390/molecules27227789.
Is liquid biopsy mature enough for the diagnosis of Alzheimer's disease?.
Gong X, Zhang H, Liu X, Liu Y, Liu J, Fapohunda F Front Aging Neurosci. 2022; 14:977999.
PMID: 35992602 PMC: 9389010. DOI: 10.3389/fnagi.2022.977999.